Carbapenem-resistant Enterobacteriaceae in the community: a scoping review

International Journal of Antimicrobial Agents

Volumn 50, Issue 2, 2017, Pages 127-134

  Kelly, Ana M ^a   Mathema, Barun ^b   Larson, Elaine L ^a,b  

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

Antimicrobial resistance; Carbapenem resistant Enterobacteriaceae; Community associated infections

Indexed keywords

CARBAPENEM; CARBAPENEMASE;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; COMMUNITY ACQUIRED INFECTION; COMMUNITY CARE; COMORBIDITY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; GRAM NEGATIVE BACTERIUM; HEALTH CARE; HUMAN; INDIA; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SYSTEMATIC REVIEW; UNITED KINGDOM; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; GLOBAL HEALTH; ISOLATION AND PURIFICATION; MICROBIOLOGY;

CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; COMMUNITY-ACQUIRED INFECTIONS; ENTEROBACTERIACEAE INFECTIONS; GLOBAL HEALTH; HUMANS; PREVALENCE;

EID: 85023746736     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2017.03.012     Document Type: Review

References (55)

1. US Centers for Disease Control and Prevention (CDC), Antibiotic resistance threats in the United States. Available from: http://www.cdc.gov/drugresistance/threat-report-2013/, 2013 [Accessed 4 June 2016].
2. The White House, Report to the president on combating antibiotic resistance: executive order of the president. President's Council of Advisors on Science and Technology; Available from: https://www.whitehouse.gov/the-press-office/2015/03/27/fact-sheet-obama-administration-releases-national-action-plan-combat-ant, 2014 [Accessed 4 June 2016].
3. The Center for Disease Dynamics, Economics & Policy (CCDEP), The state of the world's antibiotics. Available from: http://cddep.org/publications/state_worlds_antibiotics_2015, 2015 [Accessed 4 June 2016].
4. Van Duin, D., Kaye, K.S., Neuner, E.A., Bonomo, R.A., Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 75 (2013), 115–120.
5. Gupta, N., Limbago, B.M., Patel, J.B., Kallen, A.J., Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53 (2011), 60–67.
6. US Centers for Disease Control and Prevention (CDC), Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE)—November 2015 update CRE toolkit. Available from: http://www.cdc.gov/hai/organisms/cre/cre-toolkit/, 2015 [Accessed 4 June 2016].
7. National Institute of Allergy and Infectious Diseases (NIAID), NIAID's Antibacterial Resistance Program: current status and future directions. Available from: https://www.niaid.nih.gov/sites/default/files/arstrategicplan2014.pdf, 2014 [Accessed 19 June 2017].
8. Ebrahimi, F., Mózes, J., Mészáros, J., Juhász, Á., Kardos, G., Carriage rates and characteristics of Enterobacteriaceae producing extended-spectrum β-lactamases in healthy individuals: comparison of applicants for long-term care and individuals screened for employment purposes. Chemotherapy 60 (2014), 239–249.
9. Salles, M.J.C., Zurita, J., Mejía, C., Villegas, M.V., Resistant Gram-negative infections in the outpatient setting in Latin America. Epidemiol Infect 141 (2013), 2459–2472.
10. Munoz-Price, L.S., Poirel, L., Bonomo, R.A., Schwaber, M.J., Daikos, G.L., Cormican, M., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13 (2013), 785–796.
11. Cantón, R., Akóva, M., Carmeli, Y., Giske, C.G., Glupczynski, Y., Gniadkowski, M., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18 (2012), 413–431.
12. Savard, P., Perl, T.M., Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect 20 (2014), 854–861.
13. Tängdén, T., Giske, C.G., Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med 277 (2015), 501–512.
14. Nordmann, P., Poirel, L., The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20 (2014), 821–830.
15. Hayden, M.K., Lin, M.Y., Lolans, K., Weiner, S., Blom, D., Moore, N.M., et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 60 (2015), 1153–1161.
16. Thaden, J.T., Lewis, S.S., Hazen, K.C., Huslage, K., Fowler, V.G. Jr, Moehring, R.W., et al. Rising rates of carbapenem-resistant Enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. Infect Control Hosp Epidemiol 35 (2014), 978–983.
17. Bush, K., Proliferation and significance of clinically relevant β-lactamases. Ann N Y Acad Sci 1277 (2013), 84–90.
18. Schwaber, M.J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 52 (2011), 1–8.
19. Kim, Y., Cunningham, M.A., Mire, J., Tesar, C., Sacchettini, J., Joachimiak, A., NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J 27 (2013), 1917–1927.
20. US Centers for Disease Control and Prevention (CDC), Healthcare-associated infections (HAIs). Tracking CRE infections. Available from: http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html#CREmap, 2016 [Accessed 4 June 2016].
21. Rossi Gonçalves, I., Ferreira, M.L., Araujo, B.F., Campos, P.A., Royer, S., Batistão, D.W., et al. Outbreaks of colistin-resistant and colistin susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit. J Hosp Infect 94 (2016), 322–329.
22. Ergönül, Ö., Aydin, M., Azap, A., Başaran, S., Tekin, S., Kaya, Ş., et al. Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect 94 (2016), 381–385.
23. CTX-M on a novel IncF plasmid: first report of mcr-1 in the USA. Antimicrob Agents Chemother 60 (2016), 4420–4421 Erratum in: Antimicrob Agents Chemother 2016;60:5107.
24. Chen, L., Mathema, B., Chavda, K.D., DeLeo, F.R., Bonomo, R.A., Kreiswirth, B.N., Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 22 (2014), 686–696.
25. Guh, A.Y., Bulens, S.N., Mu, Y., Jacob, J.T., Reno, J., Scott, J., et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012–2013. JAMA 314 (2015), 1479–1487.
26. Temkin, E., Adler, A., Lerner, A., Carmeli, Y., Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci 1323 (2014), 22–42.
27. Lerner, A., Adler, A., Abu-Hanna, J., Percia, S.C., Matalon, M.K., Carmeli, Y., Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration. Clin Microbiol Infect, 21, 2014, 470 e1-7.
28. European Centre for Disease Prevention and Control (ECDC), Antimicrobial resistance surveillance in Europe. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available from: http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf, 2014 [Accessed 4 June 2016].
29. Villar, H.E., Baserni, M.N., Jugo, M.B., Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings. J Infect Dev Ctries 7 (2013), 630–634.
30. Kumarasamy, K.K., Toleman, M.A., Walsh, T.R., Bagaria, J., Butt, F., Balakrishnan, R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10 (2010), 597–602.
31. Tischendorf, J., de Avila, R.A., Safdar, N., Risk of infection following colonization with carbapenem-resistant Enterobacteriaceae: a systematic review. Am J Infect Control 44 (2016), 539–543.
32. Pham, M.T., Rajić, A., Greig, J.D., Sargeant, J.M., Papadopoulos, A., McEwen, S.A., A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods 5 (2014), 371–385.
33. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 (2009), 264–269.
34. Yigit, H., Queenan, A.M., Anderson, G.J., Domenech-Sanchez, A., Biddle, J.W., Steward, C.D., et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45 (2001), 1151–1161.
35. Tang, H.J., Hsieh, C.F., Chang, P.C., Chen, J.J., Lin, Y.H., Lai, C.C., et al. Clinical significance of community- and healthcare-acquired carbapenem-resistant Enterobacteriaceae isolates. PLoS ONE, 11, 2016 e0151897.
36. Miller, B.M., Johnson, S.W., Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: development of a bedside clinical score for risk assessment. Am J Infect Control 44 (2015), 134–137.
37. Coccolini, F., Sartelli, M., Catena, F., Montori, G., Di Saverio, S., Sugrue, M., et al. Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study. Int J Surg 21 (2015), 32–37.
38. Vlieghe, E.R., Huang, T.D., Phe, T., Bogaerts, P., Berhin, C., De Smet, B., et al. Prevalence and distribution of β-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia. Eur J Clin Microbiol Infect Dis 34 (2015), 1223–1229.
39. Lohiya, A., Kant, S., Kapil, A., Gupta, S.K., Misra, P., Rai, S.K., Pattern of antibiotic resistance among community derived isolates of Enterobacteriaceae using urine sample: a study from northern India. J Clin Diagn Res 9 (2015), LC15–19.
40. Garrido, A., Seral, C., Gude, M.J., Casado, C., González-Domínguez, M., Sáenz, Y., et al. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain. Microb Drug Resist 20 (2014), 301–304.
41. Rai, S., Das, D., Niranjan, D.K., Singh, N.P., Kaur, I.R., Carriage prevalence of carbapenem-resistant Enterobacteriaceae in stool samples: a surveillance study. Australas Med J 7 (2014), 64–67.
42. Brennan, B.M., Coyle, J.R., Marchaim, D., Pogue, J.M., Boehme, M., Finks, J., et al. Statewide surveillance of carbapenem-resistant Enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol 35 (2014), 342–349.
43. Turnidge, J.D., Gottlieb, T., Mitchell, D.H., Coombs, G.W., Pearson, J.C., Bell, J.M., Australian group on antimicrobial resistance community-onset gram-negative surveillance program: annual report, 2010. Commun Dis Intell Q Rep 37 (2013), E219–23.
44. Sheng, W.H., Badal, R.E., Hseuh, P.-R., Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in Asia-Pacific: the Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 57 (2013), 2981–2988.
45. Alexopoulou, A., Papadopoulos, N., Eliopoulos, D.G., Alexaki, A., Tsiriga, A., Toutouza, M., et al. Increasing frequency of Gram-positive cocci and Gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis. Liver Int 33 (2013), 975–981.
46. Gijón, D., Curiao, T., Baquero, F., Coque, T.M., Cantón, R., Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients. J Clin Microbiol 50 (2012), 1558–1563.
47. Friedman, N.D., Kaye, K.S., Stout, J.E., McGarry, S.A., Trivette, S.L., Briggs, J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 (2002), 791–797.
48. David, M.Z., Glikman, D., Crawford, S.E., Peng, J., King, K.J., Hostetler, M.A., et al. What is community-associated methicillin-resistant Staphylococcus aureus?. J Infect Dis 197 (2008), 1235–1243.
49. US Centers for Disease Control and Prevention (CDC), Multidrug-resistant organism & Clostridium difficile infection (MDRO/CDI) module. CDC; Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf, 2016 [Accessed 4 June 2016].
50. Cascio, G.L., Soldani, F., Mazzariol, A., Lleo, M.M., The high incidence of carbapenem-resistant Klebsiella pneumoniae in urine from elderly hospital patients may facilitate the spread of resistant strains to the community. Microb Drug Resist 20 (2014), 67–72.
51. Prabaker, K., Lin, M.Y., McNally, M., Cherabuddi, K., Ahmed, S., Norris, A., et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control 33 (2012), 1193–1199.
52. Yaffee, A.Q., Roser, L., Daniels, K., Humbaugh, K., Brawley, R., Thoroughman, D., et al. Notes from the field: Verona integron-encoded metallo-β-lactamase-producing carbapenem-resistant Enterobacteriaceae in a neonatal and adult intensive care unit—Kentucky, 2015. MMWR Morb Mortal Wkly Rep, 65, 2016, 190.
53. Walsh, T.R., Weeks, J., Livermore, D.M., Toleman, M.A., Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11 (2011), 355–362.
54. Liu, Y.Y., Wang, Y., Walsh, T.R., Yi, L.X., Zhang, R., Spencer, J., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16 (2015), 161–168.
55. Pecora, N.D., Li, N., Allard, M., Li, C., Albano, E., Delaney, M., et al. Genomically informed surveillance for carbapenem-resistant Enterobacteriaceae in a health care system. MBio, 6, 2015 e01030–15.